Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Chemical Research Raises Stakes In Antibody Firm BioMatrix

This article was originally published in PharmAsia News

Executive Summary

Hygo Prefecture-based drug maker Japan Chemical Research increased its holding shares from 8.8 percent to 39.9 percent in Chiba Prefecture-based biotech venture BioMatrix Research. Supported by the Tokyo Institute of Industry and a research partner for JCR, BioMatrix analyzes DNA sequencing and conducts monoclonal antibody research. JCR aims to develop more effective antibody medicines through combining BMR expertise in antibody manufacturing technology. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072927

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel